CellRapeutics™ Leukopak from Myocardial Infarction Donor (XS-0426-XU284)

Name: CellRapeutics™ Leukopak from Myocardial Infarction Donor
SKU: XS-0426-XU284
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Collected from donors with a clinical history of Myocardial Infarction, this Leukopak captures the systemic inflammatory legacy of acute cardiac ischemia. The leucocyte population often exhibits a heightened state of myeloid activation and altered wound-healing signaling in T-helper cells. It is a critical resource for studying the "cardio-immune" response and the mechanisms of post-infarct ventricular remodeling and repair.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Myocardial Infarction Donor

Cat. No.
XS-0426-XU284

Donor Age
Middle-Aged, Senior

Donor Health
Donors with a history of MI. Leukocytes reflect the systemic inflammatory response to cardiac tissue necrosis and the subsequent immune signaling involved in post-ischemic myocardial healing and remodeling.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose or Heparin, formulated to capture the acute or convalescent phase inflammatory cell dynamics efficiently.

Additional Donor Information
Each lot features a Leukopak from donors with a history of MI. Profiles specify the time elapsed since the ischemic event and current cardiac function, supporting research into post-infarct immune remodeling.

Clinical Profile
Time since the most recent MI event, type of MI, cardiac enzyme history, and details of interventions.

Additional Information

Medication History
Available upon request. Documentation of Dual Antiplatelet Therapy, statins, beta-blockers, and ACE inhibitors following acute cardiac events.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Myocardial Infarction Donor, Leukopak, Myocardial Infarction

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Myocardial Infarction Donor (XS-0426-XU284). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.